img

Global Muscle Relaxers Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Muscle Relaxers Market Insights, Forecast to 2034

Muscle relaxers are a group of drugs that have a sedative effect and may be prescribed for back, neck, and other musculoskeletal pain.
Market Analysis and InsightsGlobal Muscle Relaxers Market
Global Muscle Relaxers market is expected to reach to US$ 3912 million in 2023, with a positive growth of %, compared with US$ 3740 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Muscle Relaxers industry is evaluated to reach US$ 5065.3 million in 2033. The CAGR will be 4.4% during 2023 to 2033.
According to a study of Global Burden of Disease (GBD) 2021 data, 1.71 billion individuals globally suffer from musculoskeletal diseases, such as osteoarthritis, rheumatoid arthritis, neck discomfort, low back pain, fractures, and other injuries. People of all ages are afflicted by musculoskeletal problems; however, the prevalence varies by age and diagnosis. With over 149 million years lived with disability (YLDs), or 17% of all YLDs worldwide, musculoskeletal diseases are the main cause of YLDs. The need for muscle relaxants drugs is also being driven by the growing geriatric population, as this group is more vulnerable to illnesses including back pain, muscular tightness, and muscle spasms, especially those connected to injuries to the spine. As a result of this disease muscle relaxants are more in demand, which further drives market growth. For instance, 1 in 6 people worldwide will be 60 or older by 2030. The number of individuals in the world who are 60 or older will double (to 2.1 billion) by 2050. Between 2020 and 2050, the number of people 80 or older is projected to triple, reaching 426 million.
Report Covers
This report presents an overview of global Muscle Relaxers market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Muscle Relaxers market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Pfizer
Allergan
Ipsen Group
Teva Pharmaceuticals
Novartis
Johnson & Johnson
Takeda Pharmaceutical
Sun Pharmaceutical
Merz Pharma
Mylan
Fresenius Kabi
Endo International
Par Sterile Products
Acorda Therapeutics
SteriMax Inc
Emcure Pharmaceuticals
Upsher-Smith Laboratories
Orient Pharma
Daewoong Pharmaceutical
Segment by Type
Methocarbamol
Cyclobenzaprine
Tizanidine
Baclofen
Others

Segment by Application


Online Pharmacies
Retail Pharmacies
Hospital Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Muscle Relaxers introduction, etc. Muscle Relaxers Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Muscle Relaxers
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Muscle Relaxers Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Methocarbamol
1.2.3 Cyclobenzaprine
1.2.4 Tizanidine
1.2.5 Baclofen
1.2.6 Others
1.3 Market by Application
1.3.1 Global Muscle Relaxers Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Online Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Hospital Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Muscle Relaxers Market Perspective (2018-2033)
2.2 Global Muscle Relaxers Growth Trends by Region
2.2.1 Muscle Relaxers Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Muscle Relaxers Historic Market Size by Region (2018-2023)
2.2.3 Muscle Relaxers Forecasted Market Size by Region (2024-2033)
2.3 Muscle Relaxers Market Dynamics
2.3.1 Muscle Relaxers Industry Trends
2.3.2 Muscle Relaxers Market Drivers
2.3.3 Muscle Relaxers Market Challenges
2.3.4 Muscle Relaxers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Muscle Relaxers by Players
3.1.1 Global Muscle Relaxers Revenue by Players (2018-2023)
3.1.2 Global Muscle Relaxers Revenue Market Share by Players (2018-2023)
3.2 Global Muscle Relaxers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Muscle Relaxers, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Muscle Relaxers Market Concentration Ratio
3.4.1 Global Muscle Relaxers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Muscle Relaxers Revenue in 2022
3.5 Global Key Players of Muscle Relaxers Head office and Area Served
3.6 Global Key Players of Muscle Relaxers, Product and Application
3.7 Global Key Players of Muscle Relaxers, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Muscle Relaxers Breakdown Data by Type
4.1 Global Muscle Relaxers Historic Market Size by Type (2018-2023)
4.2 Global Muscle Relaxers Forecasted Market Size by Type (2024-2033)
5 Muscle Relaxers Breakdown Data by Application
5.1 Global Muscle Relaxers Historic Market Size by Application (2018-2023)
5.2 Global Muscle Relaxers Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Muscle Relaxers Market Size (2018-2033)
6.2 North America Muscle Relaxers Market Size by Type
6.2.1 North America Muscle Relaxers Market Size by Type (2018-2023)
6.2.2 North America Muscle Relaxers Market Size by Type (2024-2033)
6.2.3 North America Muscle Relaxers Market Share by Type (2018-2033)
6.3 North America Muscle Relaxers Market Size by Application
6.3.1 North America Muscle Relaxers Market Size by Application (2018-2023)
6.3.2 North America Muscle Relaxers Market Size by Application (2024-2033)
6.3.3 North America Muscle Relaxers Market Share by Application (2018-2033)
6.4 North America Muscle Relaxers Market Size by Country
6.4.1 North America Muscle Relaxers Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Muscle Relaxers Market Size by Country (2018-2023)
6.4.3 North America Muscle Relaxers Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Muscle Relaxers Market Size (2018-2033)
7.2 Europe Muscle Relaxers Market Size by Type
7.2.1 Europe Muscle Relaxers Market Size by Type (2018-2023)
7.2.2 Europe Muscle Relaxers Market Size by Type (2024-2033)
7.2.3 Europe Muscle Relaxers Market Share by Type (2018-2033)
7.3 Europe Muscle Relaxers Market Size by Application
7.3.1 Europe Muscle Relaxers Market Size by Application (2018-2023)
7.3.2 Europe Muscle Relaxers Market Size by Application (2024-2033)
7.3.3 Europe Muscle Relaxers Market Share by Application (2018-2033)
7.4 Europe Muscle Relaxers Market Size by Country
7.4.1 Europe Muscle Relaxers Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Muscle Relaxers Market Size by Country (2018-2023)
7.4.3 Europe Muscle Relaxers Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Muscle Relaxers Market Size (2018-2033)
8.2 China Muscle Relaxers Market Size by Type
8.2.1 China Muscle Relaxers Market Size by Type (2018-2023)
8.2.2 China Muscle Relaxers Market Size by Type (2024-2033)
8.2.3 China Muscle Relaxers Market Share by Type (2018-2033)
8.3 China Muscle Relaxers Market Size by Application
8.3.1 China Muscle Relaxers Market Size by Application (2018-2023)
8.3.2 China Muscle Relaxers Market Size by Application (2024-2033)
8.3.3 China Muscle Relaxers Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Muscle Relaxers Market Size (2018-2033)
9.2 Asia Muscle Relaxers Market Size by Type
9.2.1 Asia Muscle Relaxers Market Size by Type (2018-2023)
9.2.2 Asia Muscle Relaxers Market Size by Type (2024-2033)
9.2.3 Asia Muscle Relaxers Market Share by Type (2018-2033)
9.3 Asia Muscle Relaxers Market Size by Application
9.3.1 Asia Muscle Relaxers Market Size by Application (2018-2023)
9.3.2 Asia Muscle Relaxers Market Size by Application (2024-2033)
9.3.3 Asia Muscle Relaxers Market Share by Application (2018-2033)
9.4 Asia Muscle Relaxers Market Size by Region
9.4.1 Asia Muscle Relaxers Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Muscle Relaxers Market Size by Region (2018-2023)
9.4.3 Asia Muscle Relaxers Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Muscle Relaxers Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Muscle Relaxers Market Size by Type
10.2.1 Middle East, Africa, and Latin America Muscle Relaxers Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Muscle Relaxers Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Muscle Relaxers Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Muscle Relaxers Market Size by Application
10.3.1 Middle East, Africa, and Latin America Muscle Relaxers Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Muscle Relaxers Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Muscle Relaxers Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Muscle Relaxers Market Size by Country
10.4.1 Middle East, Africa, and Latin America Muscle Relaxers Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Muscle Relaxers Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Muscle Relaxers Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Muscle Relaxers Introduction
11.1.4 Pfizer Revenue in Muscle Relaxers Business (2018-2023)
11.1.5 Pfizer Recent Developments
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Muscle Relaxers Introduction
11.2.4 Allergan Revenue in Muscle Relaxers Business (2018-2023)
11.2.5 Allergan Recent Developments
11.3 Ipsen Group
11.3.1 Ipsen Group Company Details
11.3.2 Ipsen Group Business Overview
11.3.3 Ipsen Group Muscle Relaxers Introduction
11.3.4 Ipsen Group Revenue in Muscle Relaxers Business (2018-2023)
11.3.5 Ipsen Group Recent Developments
11.4 Teva Pharmaceuticals
11.4.1 Teva Pharmaceuticals Company Details
11.4.2 Teva Pharmaceuticals Business Overview
11.4.3 Teva Pharmaceuticals Muscle Relaxers Introduction
11.4.4 Teva Pharmaceuticals Revenue in Muscle Relaxers Business (2018-2023)
11.4.5 Teva Pharmaceuticals Recent Developments
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Muscle Relaxers Introduction
11.5.4 Novartis Revenue in Muscle Relaxers Business (2018-2023)
11.5.5 Novartis Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Muscle Relaxers Introduction
11.6.4 Johnson & Johnson Revenue in Muscle Relaxers Business (2018-2023)
11.6.5 Johnson & Johnson Recent Developments
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Details
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Muscle Relaxers Introduction
11.7.4 Takeda Pharmaceutical Revenue in Muscle Relaxers Business (2018-2023)
11.7.5 Takeda Pharmaceutical Recent Developments
11.8 Sun Pharmaceutical
11.8.1 Sun Pharmaceutical Company Details
11.8.2 Sun Pharmaceutical Business Overview
11.8.3 Sun Pharmaceutical Muscle Relaxers Introduction
11.8.4 Sun Pharmaceutical Revenue in Muscle Relaxers Business (2018-2023)
11.8.5 Sun Pharmaceutical Recent Developments
11.9 Merz Pharma
11.9.1 Merz Pharma Company Details
11.9.2 Merz Pharma Business Overview
11.9.3 Merz Pharma Muscle Relaxers Introduction
11.9.4 Merz Pharma Revenue in Muscle Relaxers Business (2018-2023)
11.9.5 Merz Pharma Recent Developments
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Mylan Business Overview
11.10.3 Mylan Muscle Relaxers Introduction
11.10.4 Mylan Revenue in Muscle Relaxers Business (2018-2023)
11.10.5 Mylan Recent Developments
11.11 Fresenius Kabi
11.11.1 Fresenius Kabi Company Details
11.11.2 Fresenius Kabi Business Overview
11.11.3 Fresenius Kabi Muscle Relaxers Introduction
11.11.4 Fresenius Kabi Revenue in Muscle Relaxers Business (2018-2023)
11.11.5 Fresenius Kabi Recent Developments
11.12 Endo International
11.12.1 Endo International Company Details
11.12.2 Endo International Business Overview
11.12.3 Endo International Muscle Relaxers Introduction
11.12.4 Endo International Revenue in Muscle Relaxers Business (2018-2023)
11.12.5 Endo International Recent Developments
11.13 Par Sterile Products
11.13.1 Par Sterile Products Company Details
11.13.2 Par Sterile Products Business Overview
11.13.3 Par Sterile Products Muscle Relaxers Introduction
11.13.4 Par Sterile Products Revenue in Muscle Relaxers Business (2018-2023)
11.13.5 Par Sterile Products Recent Developments
11.14 Acorda Therapeutics
11.14.1 Acorda Therapeutics Company Details
11.14.2 Acorda Therapeutics Business Overview
11.14.3 Acorda Therapeutics Muscle Relaxers Introduction
11.14.4 Acorda Therapeutics Revenue in Muscle Relaxers Business (2018-2023)
11.14.5 Acorda Therapeutics Recent Developments
11.15 SteriMax Inc
11.15.1 SteriMax Inc Company Details
11.15.2 SteriMax Inc Business Overview
11.15.3 SteriMax Inc Muscle Relaxers Introduction
11.15.4 SteriMax Inc Revenue in Muscle Relaxers Business (2018-2023)
11.15.5 SteriMax Inc Recent Developments
11.16 Emcure Pharmaceuticals
11.16.1 Emcure Pharmaceuticals Company Details
11.16.2 Emcure Pharmaceuticals Business Overview
11.16.3 Emcure Pharmaceuticals Muscle Relaxers Introduction
11.16.4 Emcure Pharmaceuticals Revenue in Muscle Relaxers Business (2018-2023)
11.16.5 Emcure Pharmaceuticals Recent Developments
11.17 Upsher-Smith Laboratories
11.17.1 Upsher-Smith Laboratories Company Details
11.17.2 Upsher-Smith Laboratories Business Overview
11.17.3 Upsher-Smith Laboratories Muscle Relaxers Introduction
11.17.4 Upsher-Smith Laboratories Revenue in Muscle Relaxers Business (2018-2023)
11.17.5 Upsher-Smith Laboratories Recent Developments
11.18 Orient Pharma
11.18.1 Orient Pharma Company Details
11.18.2 Orient Pharma Business Overview
11.18.3 Orient Pharma Muscle Relaxers Introduction
11.18.4 Orient Pharma Revenue in Muscle Relaxers Business (2018-2023)
11.18.5 Orient Pharma Recent Developments
11.19 Daewoong Pharmaceutical
11.19.1 Daewoong Pharmaceutical Company Details
11.19.2 Daewoong Pharmaceutical Business Overview
11.19.3 Daewoong Pharmaceutical Muscle Relaxers Introduction
11.19.4 Daewoong Pharmaceutical Revenue in Muscle Relaxers Business (2018-2023)
11.19.5 Daewoong Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Muscle Relaxers Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Methocarbamol
Table 3. Key Players of Cyclobenzaprine
Table 4. Key Players of Tizanidine
Table 5. Key Players of Baclofen
Table 6. Key Players of Others
Table 7. Global Muscle Relaxers Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 8. Global Muscle Relaxers Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Muscle Relaxers Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Muscle Relaxers Market Share by Region (2018-2023)
Table 11. Global Muscle Relaxers Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Muscle Relaxers Market Share by Region (2024-2033)
Table 13. Muscle Relaxers Market Trends
Table 14. Muscle Relaxers Market Drivers
Table 15. Muscle Relaxers Market Challenges
Table 16. Muscle Relaxers Market Restraints
Table 17. Global Muscle Relaxers Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Muscle Relaxers Revenue Share by Players (2018-2023)
Table 19. Global Top Muscle Relaxers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Muscle Relaxers as of 2022)
Table 20. Global Muscle Relaxers Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Muscle Relaxers Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Muscle Relaxers, Headquarters and Area Served
Table 23. Global Key Players of Muscle Relaxers, Product and Application
Table 24. Global Key Players of Muscle Relaxers, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Muscle Relaxers Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Muscle Relaxers Revenue Market Share by Type (2018-2023)
Table 28. Global Muscle Relaxers Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Muscle Relaxers Revenue Market Share by Type (2024-2033)
Table 30. Global Muscle Relaxers Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Muscle Relaxers Revenue Share by Application (2018-2023)
Table 32. Global Muscle Relaxers Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Muscle Relaxers Revenue Share by Application (2024-2033)
Table 34. North America Muscle Relaxers Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Muscle Relaxers Market Size by Type (2024-2033) & (US$ Million)
Table 36. North America Muscle Relaxers Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Muscle Relaxers Market Size by Application (2024-2033) & (US$ Million)
Table 38. North America Muscle Relaxers Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. North America Muscle Relaxers Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Muscle Relaxers Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe Muscle Relaxers Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Muscle Relaxers Market Size by Type (2024-2033) & (US$ Million)
Table 43. Europe Muscle Relaxers Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Muscle Relaxers Market Size by Application (2024-2033) & (US$ Million)
Table 45. Europe Muscle Relaxers Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Europe Muscle Relaxers Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Muscle Relaxers Market Size by Country (2024-2033) & (US$ Million)
Table 48. China Muscle Relaxers Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Muscle Relaxers Market Size by Type (2024-2033) & (US$ Million)
Table 50. China Muscle Relaxers Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Muscle Relaxers Market Size by Application (2024-2033) & (US$ Million)
Table 52. Asia Muscle Relaxers Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Muscle Relaxers Market Size by Type (2024-2033) & (US$ Million)
Table 54. Asia Muscle Relaxers Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Muscle Relaxers Market Size by Application (2024-2033) & (US$ Million)
Table 56. Asia Muscle Relaxers Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 57. Asia Muscle Relaxers Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Muscle Relaxers Market Size by Region (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Muscle Relaxers Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Muscle Relaxers Market Size by Type (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Muscle Relaxers Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Muscle Relaxers Market Size by Application (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Muscle Relaxers Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 64. Middle East, Africa, and Latin America Muscle Relaxers Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Muscle Relaxers Market Size by Country (2024-2033) & (US$ Million)
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Muscle Relaxers Product
Table 69. Pfizer Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 70. Pfizer Recent Developments
Table 71. Allergan Company Details
Table 72. Allergan Business Overview
Table 73. Allergan Muscle Relaxers Product
Table 74. Allergan Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 75. Allergan Recent Developments
Table 76. Ipsen Group Company Details
Table 77. Ipsen Group Business Overview
Table 78. Ipsen Group Muscle Relaxers Product
Table 79. Ipsen Group Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 80. Ipsen Group Recent Developments
Table 81. Teva Pharmaceuticals Company Details
Table 82. Teva Pharmaceuticals Business Overview
Table 83. Teva Pharmaceuticals Muscle Relaxers Product
Table 84. Teva Pharmaceuticals Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 85. Teva Pharmaceuticals Recent Developments
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Muscle Relaxers Product
Table 89. Novartis Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 90. Novartis Recent Developments
Table 91. Johnson & Johnson Company Details
Table 92. Johnson & Johnson Business Overview
Table 93. Johnson & Johnson Muscle Relaxers Product
Table 94. Johnson & Johnson Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 95. Johnson & Johnson Recent Developments
Table 96. Takeda Pharmaceutical Company Details
Table 97. Takeda Pharmaceutical Business Overview
Table 98. Takeda Pharmaceutical Muscle Relaxers Product
Table 99. Takeda Pharmaceutical Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 100. Takeda Pharmaceutical Recent Developments
Table 101. Sun Pharmaceutical Company Details
Table 102. Sun Pharmaceutical Business Overview
Table 103. Sun Pharmaceutical Muscle Relaxers Product
Table 104. Sun Pharmaceutical Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 105. Sun Pharmaceutical Recent Developments
Table 106. Merz Pharma Company Details
Table 107. Merz Pharma Business Overview
Table 108. Merz Pharma Muscle Relaxers Product
Table 109. Merz Pharma Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 110. Merz Pharma Recent Developments
Table 111. Mylan Company Details
Table 112. Mylan Business Overview
Table 113. Mylan Muscle Relaxers Product
Table 114. Mylan Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 115. Mylan Recent Developments
Table 116. Fresenius Kabi Company Details
Table 117. Fresenius Kabi Business Overview
Table 118. Fresenius Kabi Muscle Relaxers Product
Table 119. Fresenius Kabi Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 120. Fresenius Kabi Recent Developments
Table 121. Endo International Company Details
Table 122. Endo International Business Overview
Table 123. Endo International Muscle Relaxers Product
Table 124. Endo International Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 125. Endo International Recent Developments
Table 126. Par Sterile Products Company Details
Table 127. Par Sterile Products Business Overview
Table 128. Par Sterile Products Muscle Relaxers Product
Table 129. Par Sterile Products Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 130. Par Sterile Products Recent Developments
Table 131. Acorda Therapeutics Company Details
Table 132. Acorda Therapeutics Business Overview
Table 133. Acorda Therapeutics Muscle Relaxers Product
Table 134. Acorda Therapeutics Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 135. Acorda Therapeutics Recent Developments
Table 136. SteriMax Inc Company Details
Table 137. SteriMax Inc Business Overview
Table 138. SteriMax Inc Muscle Relaxers Product
Table 139. SteriMax Inc Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 140. SteriMax Inc Recent Developments
Table 141. Emcure Pharmaceuticals Company Details
Table 142. Emcure Pharmaceuticals Business Overview
Table 143. Emcure Pharmaceuticals Muscle Relaxers Product
Table 144. Emcure Pharmaceuticals Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 145. Emcure Pharmaceuticals Recent Developments
Table 146. Upsher-Smith Laboratories Company Details
Table 147. Upsher-Smith Laboratories Business Overview
Table 148. Upsher-Smith Laboratories Muscle Relaxers Product
Table 149. Upsher-Smith Laboratories Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 150. Upsher-Smith Laboratories Recent Developments
Table 151. Orient Pharma Company Details
Table 152. Orient Pharma Business Overview
Table 153. Orient Pharma Muscle Relaxers Product
Table 154. Orient Pharma Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 155. Orient Pharma Recent Developments
Table 156. Daewoong Pharmaceutical Company Details
Table 157. Daewoong Pharmaceutical Business Overview
Table 158. Daewoong Pharmaceutical Muscle Relaxers Product
Table 159. Daewoong Pharmaceutical Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 160. Daewoong Pharmaceutical Recent Developments
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Muscle Relaxers Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Muscle Relaxers Market Share by Type: 2022 VS 2033
Figure 3. Methocarbamol Features
Figure 4. Cyclobenzaprine Features
Figure 5. Tizanidine Features
Figure 6. Baclofen Features
Figure 7. Others Features
Figure 8. Global Muscle Relaxers Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 9. Global Muscle Relaxers Market Share by Application: 2022 VS 2033
Figure 10. Online Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Hospital Pharmacies Case Studies
Figure 13. Muscle Relaxers Report Years Considered
Figure 14. Global Muscle Relaxers Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Muscle Relaxers Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Muscle Relaxers Market Share by Region: 2022 VS 2033
Figure 17. Global Muscle Relaxers Market Share by Players in 2022
Figure 18. Global Top Muscle Relaxers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Muscle Relaxers as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Muscle Relaxers Revenue in 2022
Figure 20. North America Muscle Relaxers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Muscle Relaxers Market Share by Type (2018-2033)
Figure 22. North America Muscle Relaxers Market Share by Application (2018-2033)
Figure 23. North America Muscle Relaxers Market Share by Country (2018-2033)
Figure 24. United States Muscle Relaxers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Muscle Relaxers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Muscle Relaxers Market Size YoY (2018-2033) & (US$ Million)
Figure 27. Europe Muscle Relaxers Market Share by Type (2018-2033)
Figure 28. Europe Muscle Relaxers Market Share by Application (2018-2033)
Figure 29. Europe Muscle Relaxers Market Share by Country (2018-2033)
Figure 30. Germany Muscle Relaxers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. France Muscle Relaxers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. U.K. Muscle Relaxers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Italy Muscle Relaxers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Russia Muscle Relaxers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Nordic Countries Muscle Relaxers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. China Muscle Relaxers Market Size YoY (2018-2033) & (US$ Million)
Figure 37. China Muscle Relaxers Market Share by Type (2018-2033)
Figure 38. China Muscle Relaxers Market Share by Application (2018-2033)
Figure 39. Asia Muscle Relaxers Market Size YoY (2018-2033) & (US$ Million)
Figure 40. Asia Muscle Relaxers Market Share by Type (2018-2033)
Figure 41. Asia Muscle Relaxers Market Share by Application (2018-2033)
Figure 42. Asia Muscle Relaxers Market Share by Region (2018-2033)
Figure 43. Japan Muscle Relaxers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. South Korea Muscle Relaxers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. China Taiwan Muscle Relaxers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Southeast Asia Muscle Relaxers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. India Muscle Relaxers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Australia Muscle Relaxers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Muscle Relaxers Market Size YoY (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Muscle Relaxers Market Share by Type (2018-2033)
Figure 51. Middle East, Africa, and Latin America Muscle Relaxers Market Share by Application (2018-2033)
Figure 52. Middle East, Africa, and Latin America Muscle Relaxers Market Share by Country (2018-2033)
Figure 53. Brazil Muscle Relaxers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Mexico Muscle Relaxers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Turkey Muscle Relaxers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia Muscle Relaxers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Israel Muscle Relaxers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. GCC Countries Muscle Relaxers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 60. Allergan Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 61. Ipsen Group Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 62. Teva Pharmaceuticals Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 63. Novartis Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 64. Johnson & Johnson Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 65. Takeda Pharmaceutical Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 66. Sun Pharmaceutical Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 67. Merz Pharma Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 68. Mylan Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 69. Fresenius Kabi Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 70. Endo International Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 71. Par Sterile Products Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 72. Acorda Therapeutics Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 73. SteriMax Inc Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 74. Emcure Pharmaceuticals Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 75. Upsher-Smith Laboratories Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 76. Orient Pharma Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 77. Daewoong Pharmaceutical Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed